Cargando…

Tigilanol Tiglate-Mediated Margins: A Comparison With Surgical Margins in Successful Treatment of Canine Mast Cell Tumours

Tigilanol tiglate (TT) is a novel small molecule registered as a veterinary pharmaceutical for intratumoural treatment of canine mast cell tumours (MCTs). The drug has a multifactorial mode of action resulting in rapid destruction of the treated tumour by haemorrhagic necrosis and subsequent slough...

Descripción completa

Detalles Bibliográficos
Autores principales: De Ridder, Thomas, Reddell, Paul, Jones, Pamela, Brown, Graham, Campbell, Justine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715915/
https://www.ncbi.nlm.nih.gov/pubmed/34977208
http://dx.doi.org/10.3389/fvets.2021.764800

Ejemplares similares